Audrey Davis
Caen, 14000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Structure-Guided Discovery of a Nonpeptidic MT5-MMP Inhibitor.
Journal: ACS medicinal chemistry letters
Published: April 17, 2026
Rational Design and Evaluation of Rivastigmine-Based Pleiotropic Prodrugs for the Treatment of Alzheimer's Disease.
Journal: ACS chemical neuroscience
Published: April 13, 2026
Rational Design and Evaluation of Rivastigmine-Based Pleiotropic Prodrugs for the Treatment of Alzheimer's Disease.
Journal: ACS chemical neuroscience
Published: April 13, 2026
Combining β2-AR agonism with butyrylcholinesterase inhibition, a synergistic neuroprotective action against Alzheimer's disease.
Journal: RSC medicinal chemistry
Published: March 30, 2026
An efficient step-by-step approach to select pleiotropic drug candidates against Alzheimer's disease: The discovery of neocopride.
Journal: Journal of Alzheimer's disease : JAD
Published: March 13, 2026
Polyfunctionalized N-Arylsulfonyl Indoles: Identification of (E)-N-Hydroxy-3-{3-[(5-(3-(piperidin-1-yl)propoxy]-1H-indol-1-yl)sulfonyl]phenyl}acrylamide (MTP150) for the Epigenetic-Based Therapy of Parkinson's Disease.
Journal: International journal of molecular sciences
Published: January 30, 2026
Access to novel potent pleiotropic prodrugs, targeting both butyrylcholinesterase and serotonin reuptake, with anti-amnesic activities in Alzheimer's disease model.
Journal: European journal of medicinal chemistry
Published: January 15, 2026
Synthesis, in vitro and in vivo biological evaluation of novel dual compounds targeting both acetylcholinesterase and serotonergic 5-HT4 receptors with potential interest in the treatment of Alzheimer's disease.
Journal: European journal of medicinal chemistry
Published: September 20, 2024
Organophosphate toxicity patterns: A new approach for assessing organophosphate neurotoxicity.
Journal: Journal of hazardous materials
Published: January 10, 2024
Development of Pleiotropic TrkB and 5-HT4 Receptor Ligands as Neuroprotective Agents.
Journal: Molecules (Basel, Switzerland)
Published: December 14, 2023
Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca2+ Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation.
Journal: Molecules (Basel, Switzerland)
Published: November 27, 2022
Active Targeted Nanoemulsions for Repurposing of Tegaserod in Alzheimer's Disease Treatment.
Journal: Pharmaceutics
Published: September 10, 2021
Last Updated: 09/26/2026